{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:44:47Z","timestamp":1771879487860,"version":"3.50.1"},"reference-count":41,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Fumaric acid esters (FAEs) are a systemic treatment for psoriasis considered to have a favourable long\u2010term safety profile without an increased risk for immunosuppression. However, progressive multifocal leukoencephalopathy (PML), a rare, opportunistic viral infection of the central nervous system, has been linked anecdotally to FAE treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess clinical features and outcomes of FAE\u2010associated PML cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Systematic literature search in multiple databases up to 25th February 2016 for reports of PML in psoriasis patients treated with FAEs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Eight cases (four male, four female) of FAE\u2010associated PML were identified. Median age was 64 years (range 42\u201374 years); median FAE treatment duration was 3 years (range 1.5\u20135 years). Six patients were treated with a formulation containing dimethyl fumarate (DMF) and monoethyl fumarates, and two patients with a DMF formulation. Patients exhibited neurological symptoms, such as aphasia, hemiparesis and dysarthria. PML diagnosis was based on MRI findings and presence of JC virus in cerebrospinal fluid and\/or brain tissue. All cases were linked to moderate\u2010to\u2010severe reductions in absolute lymphocyte counts, with nadirs ranging from 200 to 792 cells per mm<jats:sup>3<\/jats:sup>. Median exposure to lymphocytopenia was 2 years (range 1\u20135 years). In all cases, FAE treatment was discontinued; PML was treated with mefloquine plus mirtazapine. Three patients improved, two had stable disease, two had residual symptoms, and one patient died to an immune reconstitution inflammatory syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Progressive multifocal leukoencephalopathy is infrequently linked to FAE treatment, but underreporting cannot be excluded. Physicians treating patients with FAEs should be vigilant for the occurrence of PML, and both clinicians and patients should be alert for onset of new neurological symptoms. Periodic monitoring of lymphocyte counts and FAE discontinuation in case of moderate\u2010to\u2010severe lymphocytopenia is recommended to minimize the risk for PML.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.14236","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T04:42:59Z","timestamp":1490157779000},"page":"1475-1482","source":"Crossref","is-referenced-by-count":22,"title":["Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients"],"prefix":"10.1111","volume":"31","author":[{"given":"D.M.W.","family":"Balak","sequence":"first","affiliation":[{"name":"Department of Dermatology Erasmus MC University Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hajdarbegovic","sequence":"additional","affiliation":[{"name":"Department of Dermatology Erasmus MC University Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.M.","family":"Bramer","sequence":"additional","affiliation":[{"name":"Medical Library Erasmus MC University Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.A.M.","family":"Neumann","sequence":"additional","affiliation":[{"name":"Department of Dermatology Erasmus MC University Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.B.","family":"Thio","sequence":"additional","affiliation":[{"name":"Department of Dermatology Erasmus MC University Medical Center Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2004.11.003"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13128"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14500"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-015-1593-8"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12205"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4026"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1159\/000445681"},{"key":"e_1_2_5_9_1","first-page":"170","article-title":"Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty\u2010one patients","volume":"17","author":"Kokelj F","year":"2009","journal-title":"Acta Dermatovenerol Croat"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04596.x"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12849"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13354"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2003.05433.x"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2009.07120_supp.x"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1215357"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1211805"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70040-5"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-014-0294-y"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53488-0.00017-1"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-014-0303-1"},{"key":"e_1_2_5_21_1","first-page":"e20","article-title":"Progressive multifocal leukoencephalopathy and reversible progressive leukoencephalopathy syndrome in dermatologic therapy","volume":"12","author":"Ladizinski B","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7311-1"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0363-8"},{"key":"e_1_2_5_24_1","first-page":"259","article-title":"Increased nuclear Nrf2 expression after fumarate treatment for multiple sclerosis and psoriasis","volume":"23","author":"Metz I","year":"2015","journal-title":"Mult Scler"},{"key":"e_1_2_5_25_1","first-page":"1081","article-title":"Case reports of PML in patients treated for psoriasis","volume":"369","author":"Buttmann M","year":"2013","journal-title":"N Engl J Med"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000085"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1413724"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14500"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1307680"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1159\/000017903"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-016-0459-y"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1506151"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2015.05.003"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-002-0347-6"},{"key":"e_1_2_5_35_1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1684\/ejd.2013.2014","article-title":"Immunological changes in psoriasis patients under long\u2010term treatment with fumaric acid esters: risk of Kaposi sarcoma occurrence?","volume":"23","author":"Philipp S","year":"2013","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_36_1","first-page":"583","article-title":"PML in patients treated with dimethyl fumarate","volume":"373","author":"Kester MS","year":"2015","journal-title":"N Engl J Med"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.279"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1415408"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000274"},{"key":"e_1_2_5_40_1","unstructured":"European Medicines Agency (EMA).Updated recommendations to minimise the risk of the rare brain infection PML with Tecfidera. [WWW document]2015. URLhttp:\/\/wwwemaeuropaeu\/docs\/en_GB\/document_library\/Press_release\/2015\/10\/WC500196017pdf(last accessed: 31 October 2016)."},{"key":"e_1_2_5_41_1","first-page":"295","article-title":"More on PML in patients treated with dimethyl fumarate. Author reply","volume":"374","author":"Balak D","year":"2016","journal-title":"N Engl J Med"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03389.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.14236","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.14236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T23:52:03Z","timestamp":1695513123000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.14236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1111\/jdv.14236"],"URL":"https:\/\/doi.org\/10.1111\/jdv.14236","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,25]]}}}